1. Home
  2. ABUS vs ECVT Comparison

ABUS vs ECVT Comparison

Compare ABUS & ECVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbutus Biopharma Corporation

ABUS

Arbutus Biopharma Corporation

HOLD

Current Price

$4.09

Market Cap

888.5M

Sector

Health Care

ML Signal

HOLD

Logo Ecovyst Inc.

ECVT

Ecovyst Inc.

HOLD

Current Price

$11.06

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABUS
ECVT
Founded
2005
1935
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
888.5M
1.1B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
ABUS
ECVT
Price
$4.09
$11.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$5.00
$12.00
AVG Volume (30 Days)
1.6M
1.1M
Earning Date
11-13-2025
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,606,000.00
$779,147,000.00
Revenue This Year
$125.30
$8.24
Revenue Next Year
N/A
$0.93
P/E Ratio
N/A
N/A
Revenue Growth
116.64
25.22
52 Week Low
$2.71
$5.24
52 Week High
$5.10
$11.31

Technical Indicators

Market Signals
Indicator
ABUS
ECVT
Relative Strength Index (RSI) 37.84 73.43
Support Level $3.68 $10.99
Resistance Level $4.33 $11.31
Average True Range (ATR) 0.23 0.25
MACD -0.07 0.03
Stochastic Oscillator 31.18 83.62

Price Performance

Historical Comparison
ABUS
ECVT

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

About ECVT Ecovyst Inc.

Ecovyst Inc is an integrated and provider of materials, specialty catalysts and services. Its products contribute to lower emissions and cleaner air, higher fuel efficiency and cleaner fuels, and key enablers to advance transition to clean energy. The company has two reporting segments: Ecoservices and Advanced Materials & Catalysts. Ecoservices provides sulfuric acid recycling to the North American refining industry for the production of alkylate and provides on-purpose virgin sulfuric acid for water treatment, mining, and industrial applications. Maximum revenue is generated from Ecoservices segment.

Share on Social Networks: